CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in CASI Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +20 vs. Q4 2022
- Shares held
- 929.8K
- +929.7K (+929,695.0%) vs. Q4 2022
- Total value
- $2.15M
- +$2.15M (+1,202,459.8%) vs. Q4 2022
- New holders
- 20
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 257,618 | $597.7K | 0.00% | +257,618 | New |
| Wellington Shields Capital Management, LLC | 180,143 | $417.9K | 0.05% | +180,143 | New |
| Wellington Shields & Co., LLC | 139,315 | $323.2K | 0.07% | +139,315 | New |
| Geode Capital Management, LLC | 98,133 | $225.7K | 0.00% | +98,133 | New |
| BlackRock Inc. | 91,715 | $212.8K | 0.00% | +91,715 | New |
| Susquehanna International Group, LLP | 38,326 | $88.2K | 0.00% | +38,326 | New |
| State Street Corp | 35,555 | $81.8K | 0.00% | +35,555 | New |
| Northern Trust Corp | 29,825 | $69.2K | 0.00% | +29,825 | New |
| Franklin Resources Inc | 24,923 | $57.3K | 0.00% | +24,923 | New |
| Renaissance Technologies LLC | 13,100 | $30.0K | 0.00% | +13,100 | New |
| Dimensional Fund Advisors LP | 11,508 | $26.5K | 0.00% | +11,508 | New |
| UBS Group AG | 6,175 | $14.3K | 0.00% | +6,175 | New |
| Tower Research Capital LLC (TRC) | 1,674 | $4.00K | 0.00% | +1,674 | New |
| Morgan Stanley | 1,553 | $3.60K | 0.00% | +1,553 | New |
| West Paces Advisors Inc. | 100 | $232 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 62 | $144 | 0.00% | +62 | New |
| Northwestern Mutual Wealth Management Co | 13 | $30 | 0.00% | +13 | New |
| Colonial Trust Co | 11 | $26 | 0.00% | +11 | New |
| Bank of America Corp | 3 | $7 | 0.00% | +3 | New |
| JPMorgan Chase & Co | 25 | $0 | 0.00% | +25 | New |
| Royal Bank of Canada | 18 | $0 | 0.00% | +18 | New |